Adelaide Research & Scholarship
Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/14308
| Citations | ||
| Scopus | Web of Science® | Altmetric |
|---|---|---|
|
?
|
?
|
|
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Somogyi, A. | - |
| dc.date.issued | 1997 | - |
| dc.identifier.citation | Australian Prescriber, 1997; 20(3):71- | - |
| dc.identifier.issn | 0312-8008 | - |
| dc.identifier.issn | 1839-3942 | - |
| dc.identifier.uri | http://hdl.handle.net/2440/14308 | - |
| dc.description.abstract | In the treatment of migraine, pethidine is less efficacious than dihydroergotamine plus metoclopramide: it can aggravate nausea, there is a risk of dependence and it has a short duration of effect necessitating additional medication. Its use therefore cannot be substantiated. | - |
| dc.description.statementofresponsibility | Andrew A. Somogyi | - |
| dc.language.iso | en | - |
| dc.publisher | Australian Prescriber | - |
| dc.source.uri | http://www.australianprescriber.com/magazine/20/3/artid/220/ | - |
| dc.subject | headache | - |
| dc.subject | clinical trials | - |
| dc.subject | dependence | - |
| dc.subject | adverse effects | - |
| dc.title | Pethidine is inappropriate for migraine | - |
| dc.type | Journal article | - |
| dc.identifier.doi | 10.18773/austprescr.1997.061 | - |
| pubs.publication-status | Published | - |
| dc.identifier.orcid | Somogyi, A. [0000-0003-4779-0380] | - |
| Appears in Collections: | Aurora harvest 2 Pharmacology publications | |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.